Towards Healthcare
Oncology Devices Market
Updated Date: 18 March 2026   |   Report Code: 6323

Oncology Devices Market Impact of Regulatory Changes with Policy Developments

According to market projections, the oncology devices sector is expected to grow from USD 177.17 billion in 2025 to USD 914.79 billion by 2035, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards personalized medicine have accelerated the importance of medical equipment in the oncology sector. North America dominated the market in 2024, driven by high healthcare expenditure, minimally invasive procedures, and supportive reimbursement policies.

Last Updated : 18 March 2026 Category: Medical Devices Insight Code: 6323 Format: PDF / PPT / Excel

Executive Summary

1.1 Market Overview and Key Drivers
1.2 Emerging Trends and Innovations in Oncology Devices
1.3 Competitive Landscape and Positioning in the Oncology Devices Market
1.4 Key Challenges and Opportunities in the Market
1.5 Strategic Insights from Industry Experts

Introduction

2.1 Overview of Oncology Devices in Cancer Treatment
2.2 Key Industry Dynamics and Shaping Forces in the Oncology Devices Market
2.3 Related Reports and Market Intelligence on Oncology Devices
2.4 Long-term Outlook and Expected Shifts in the Oncology Devices Market

Oncology Devices Market Overview

3.1 Evolution of Oncology Devices: From Early Detection to Treatment
3.2 Key Factors Driving Market Growth in Oncology Devices
3.3 Historical Development and Current Trends in Oncology Devices
3.4 Classification and Types of Oncology Devices (Diagnostic, Therapeutic, Surgical, etc.)
3.5 Applications of Oncology Devices in Cancer Care: Screening, Treatment, and Monitoring

Technology and Treatment Landscape

4.1 Current Treatment Modalities and Technological Approaches in Oncology Devices
4.2 Recent Advancements in Oncology Devices: AI, Robotics, and Personalized Medicine
4.3 Challenges in Oncology Device Adoption and Integration into Clinical Settings
4.4 Comparative Analysis of Current and Emerging Oncology Device Solutions
4.5 Physician, Oncologist, and Patient Perspectives on Oncology Device Usage

Epidemiology/Market Segmentation

5.1 Prevalence of Cancer and Adoption of Oncology Devices
5.2 Geographic Distribution and Market Penetration of Oncology Devices
5.3 Comorbidities and Adjacent Markets Impacting the Oncology Devices Market
5.4 Market Segmentation by Device Type: Diagnostic Devices, Radiation Therapy Devices, Surgical Devices, etc.
5.5 Trends in Cancer Patient Behavior and Technological Adoption

Competitive Assessment and Key Players

6.1 Market Leaders and Innovators in the Oncology Devices Space
6.2 Competitive Landscape: Strategic Positioning of Key Competitors in Oncology Devices
6.3 Emerging Companies and Technologies to Watch in Oncology Device Development
6.4 Market Share Breakdown by Company, Device Type, and Region

Unmet Needs and Strategic Opportunities

7.1 Gaps in Current Oncology Device Technology and Solutions
7.2 Opportunities in Personalized Oncology Devices and AI Integration
7.3 Regulatory and Reimbursement Challenges Facing the Market
7.4 Addressing Patient Access and Affordability Issues for Oncology Devices
7.5 Future Opportunities in Oncology Device Market Expansion and Innovations

Regulatory and Market Access Landscape

8.1 Overview of Regulatory Pathways for Oncology Devices
8.2 Market Access Strategies and Barriers to Oncology Device Adoption
8.3 Reimbursement Models and Pricing Pressures in the Oncology Devices Market
8.4 Global Regulatory Shifts and Impact on Oncology Device Market Dynamics

R&D and Innovation Strategies

9.1 Key Research and Development Trends in Oncology Device Technology
9.2 Collaborations, Mergers, and Acquisitions in the Oncology Devices Sector
9.3 Investment Trends and Funding for Innovation in Oncology Devices
9.4 Clinical Trial Design and Development Challenges for Oncology Devices
9.5 Breakthrough Oncology Devices and Their Market Impact

Strategic Recommendations

10.1 Entry and Expansion Strategies for New Oncology Device Market Players
10.2 Strategic Recommendations for Industry Leaders in Oncology Devices
10.3 Insights into M&A and Partnership Opportunities in the Oncology Device Market
10.4 Innovations and Differentiation Strategies for Oncology Device Manufacturers
10.5 Pricing and Cost Management Strategies in the Oncology Devices Market

Future Market Outlook

11.1 Emerging Oncology Devices and Their Market Potential
11.2 Forecast for the Oncology Devices Market (X Years) with Key Growth Drivers
11.3 Impact of Regulatory Changes and Policy Developments on Oncology Device Adoption
11.4 Long-Term Strategic Trends in Oncology Device Technology and Cancer Care

Conclusion

12.1 Key Takeaways and Strategic Implications for Stakeholders in the Oncology Devices Market
12.2 Future Challenges and Opportunities in the Oncology Devices Market

Appendix

13.1 Bibliography
13.2 Abbreviations and Glossary of Terms
13.3 Methodology and Data Sources
13.4 Expert Interviews: Key Opinion Leaders (KOLs) and Stakeholder Insights
13.5 Primary Research and Market Survey Details
13.6 About the Authors and Analyst Team
13.7 Contact Information

FAQ's

Answer : The oncology devices market is valued at USD 208.78 billion in 2026 and is on track to reach USD 914.79 billion by 2035, witnessing a steady CAGR of 17.84% during the forecast span.

Answer : North America is currently leading the oncology devices market due to the rising cancer incidence, growing health awareness, and advancements in diagnostic technologies.

Answer : Some key players include Elekta, Philips, Hologic, Accuray, Stryker, GE Healthcare, etc.

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar